Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 158

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-26-2_002

تاریخ نمایه سازی: 8 دی 1401

چکیده مقاله:

Objective(s): Parkinson’s disease (PD) is one of the most incurable, chronic, and progressive neurodegenerative disorders Worldwide. Curcumin, a natural polyphenolic antioxidant compound, has a long history in traditional medicine. We investigate the effect of curcumin on brain oxidative stress, DNA fragmentation, and motor changes in rotenone-induced  PD in mice. The possible modulation of the anti-parkinsonian action of drugs L-dopa and rasagiline by curcumin was also studied.Materials and Methods: Mice received rotenone ۱.۵ mg/kg and were treated with curcumin (۱۵۰ mg/kg), L-dopa (۲۵ mg/kg), rasagiline (۱ mg/kg), L-dopa+curcumin, or rasagiline+curcumin. Striatal malondialdehyde, reduced glutathione, nitric oxide, tyrosine hydroxylase, and brain DNA fragmentations were measured. Histopathological examination of brain tissues was done. Motor coordination and behavioral tests such as wire-hanging, stair, and wood-waking tests were included.Results: Rotenone caused elevation in brain malondialdehyde and nitric oxide contents, depletion of reduced glutathione accompanied by a reduction in rearing behavior, and impairment of motor activity in wire-hanging, stair, and wood-waking tests. Also, severe DNA fragmentation in the striatum, marked decrease of substantia nigra pigmented neurons, neuronal degeneration in the cerebral cortex and hippocampus, decreased glial fibrillary acidic protein reaction (GFAP) and glial cell size in the cerebral cortex were caused by rotenone. In rotenone-treated mice, brain oxidative stress was decreased by curcumin, L-dopa, rasagiline, curcumin+L-dopa, and curcumin+rasagiline. These treatments also prevented DNA fragmentation and markedly improved the motor and behavioral impairment caused by rotenone. Rotenone-induced histopathological changes were ameliorated by curcumin which had an additive effect to that of l-dopa or rasagiline.Conclusion: These data indicate that curcumin showed additive neuroprotective effects to L-dopa or rasagiline and ameliorated neurodegeneration, DNA fragmentation, and motor defects caused by rotenone in mice. 

نویسندگان

Marwa El-Shamarka

Department of Narcotics, Ergogenics, and Poisons, Medical Research Division, National Research Centre, Cairo, Egypt

Omar Abdel-Salam

Department of Narcotics, Ergogenics, and Poisons, Medical Research Division, National Research Centre, Cairo, Egypt

Nermeen Shafee

Department of Pathology, Medical Research Division, National Research Centre, Cairo, Egypt

Hala Zeidan

Department of Research on Children with Special Needs, Medical Research Division, National Research Centre, Cairo, Egypt

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Rossi A, Berger K, Chen H, Leslie D, Mailman RB, ...
  • Jellinger KA. Recent developments in the pathology of Parkinson’s disease. ...
  • Santens P, Boon P, Van Roost D, Caemaert J. The ...
  • Manisha G, Meenakshi C, Wamik A. Therapeuic role of L-DOPA ...
  • Sahin G, Kirik D. Efficacy of L-DOPA therapy in Parkinson’s ...
  • Nayak L and Henchcliffe C. Rasagline in treatment of Parkinson ...
  • Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as ‘‘Curecumin’’: From ...
  • El-Shamarka MEA, Eliwa HA, Ahmed MAE. Inhibition of boldenone induced ...
  • Tieu, K. A guide to neurotoxic animal models of Parkinson’s ...
  • Alam M, Schmidt WJ. Rotenone destroys dopaminergic neurons and induces ...
  • Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, ...
  • Uversky V.N. Neurotoxicant induced animal models of Parkinson’s disease: understanding ...
  • Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot ...
  • Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys ۱۹۵۹; ۸۲:۷۰-۷۷. ۱۷. ...
  • Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the ...
  • Crawley JN. What’s wrong with my mouse? Behavioral phenotyping of ...
  • Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between ...
  • Baird AL, Meldrum A, Dunnett SB. The staircase test of ...
  • Chen J, Jin K, Chen M, Pei W, Kawaguchi K, ...
  • Wang JH, Gouda-Vossos A, Dzamko N, Halliday G, Huang Y. ...
  • Sherer TB, Kim JH, Betarbet R, Greenamyre JT. Subcutaneous rotenone ...
  • Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, ...
  • Abdel-Salam OME, El-Shamarka M E-S, Omara EA. Grape seed extract ...
  • Hayyan M, Hashim MA, AlNashef IM. Superoxide ion: Generation and ...
  • Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, ...
  • Chang CY, Song MJ, Yoon HJ, Jeon SB, Suk K, ...
  • Lee DH, Gold R, Linker RA. Mechanismsof oxidative damage in ...
  • Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative ...
  • Abdel-Salam OME, Sleem AA, Youness ER, Mohammed NA, Omara EA, ...
  • Bashkatova V, Alam M, Vanin A, Schmidt WJ. Chronic administration ...
  • Abdel-Salam OE, Omara EA, Youness ER, Khadrawy YA, Mohammed NA, ...
  • Forstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. ...
  • Brown GC. Nitric oxide and neuronal death. Nitric Oxide ۲۰۱۰; ...
  • Xiong ZK, Lang J, Xu G, Li HY, Zhang Y, ...
  • Henderson ND,Turri MG, DeFries JC, Flint J. QTL analysis of ...
  • El- Shamarka MEA, Kozman MR, Messiha BAS. The protective effect ...
  • Aggarwal BB, Sundaram, C, Malani N, Ichikawa H. Curcumin: The ...
  • Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. ...
  • Sreejayan S, Rao MN. Nitric oxide scavenging by curcuminoids. J ...
  • Liu Z, Yu Y, Lee X, Ross CA. Curcumin protects ...
  • Huang HC, Chang P, Dai XL, Jiang ZF. Protective effects ...
  • Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the ...
  • Floyd RA. Anti-oxidants, oxidative stress, and degenerative neurological disorders. Proc ...
  • Schapira AHV. The use of rasagiline in Parkinson’s disease. J ...
  • Mandel S, Weinreb O, Amit T, Youdim MBH. Mechanism of ...
  • Araque A, Navarrete M. Glial cells in neuronal network function. ...
  • O’Callaghan JP, Sriram K. Glial fibrillary acidic protein and related ...
  • Jia H, Liu Z, Li X, Feng Z, Hao J, ...
  • نمایش کامل مراجع